Stacy L Cooper Selected Research

Hypersensitivity (Allergy)

1/2019

Universal premedication and therapeutic drug monitoring for asparaginase-based therapy prevents infusion-associated acute adverse events and drug substitutions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stacy L Cooper Research Topics

Disease

3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2019
2	Neoplasms (Cancer) 01/2023 - 01/2020
1	Leukemia 11/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Hypersensitivity (Allergy) 01/2019
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2016
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 02/2016
1	Cytopenia 02/2016

Drug/Important Bio-Agent (IBA)

1	avapritinibIBA 11/2023
1	Phosphotransferases (Kinase)IBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2023
1	blinatumomabIBA 01/2023
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2020
1	purineIBA 01/2020
1	Allopurinol (Remid)FDA LinkGeneric 01/2020
1	pegaspargase (Oncaspar)FDA Link 01/2019
1	Asparaginase (Elspar)FDA Link 01/2019
1	Sirolimus (Rapamycin)FDA Link 02/2016

Therapy/Procedure

3	Therapeutics 11/2023 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2020 - 02/2016
1	Aftercare (After-Treatment) 01/2020